Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PO vs IV Antibiotics for Infected Nonunion of Fractures
NCT05699174Phase 3Recruiting
- Sponsor
- Major Extremity Trauma Research Consortium
- Start
- May 2023
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in nonunion of fracture (2 arms), sponsored by Major Extremity Trauma Research Consortium. Primary endpoint: Number of patients with a hospital re-admission at 1 year. Started May 2023; status: recruiting.
02
Conditions
nonunion of fracture
Beyond the preview
Go deeper on NCT05699174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05699174.